PRF Technologies PRFX
NASDAQ PRFX
$0.93 -0.03 (-3.23%)
At close: Sep 22, 2026 · 4:00 PM EDT

PRF Technologies (PRFX) Liabilities and Shareholders Equity (2019 - 2026)

PRF Technologies' (PRFX) quarterly Liabilities and Shareholders Equity came in at $19.1 million in Q2 2026, up 22626.19% on a YoY basis from N/an in Q2 2025, and up 59.11% quarter-over-quarter from $12.0 million in Q4 2025.

Analysis

PRF Technologies (PRFX) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

PRF Technologies (PRFX) has reported Liabilities and Shareholders Equity for 8 consecutive years, with $19.1 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Liabilities and Shareholders Equity rose 22626.19% year-over-year to $19.1 million; the trailing twelve-month figure through Jun 2026 stood at $35.7 million (up 172.81% YoY), and the FY2025 full-year result was $12.0 million, up 165.15% from the prior year.
  • Liabilities and Shareholders Equity grew to $19.1 million in Q2 2026 per PRFX's latest filing, from $12.0 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $19.1 million in Q2 2026 and bottomed at $84000.0 in Q2 2025.
  • Historically, Liabilities and Shareholders Equity has averaged $9.6 million across 5 years, with a median of $10.7 million in 2023.
  • The sharpest annual moves came in 2025 and 2026: Liabilities and Shareholders Equity slumped 97.3% in 2025, then jumped 22626.19% in 2026.
  • Over 5 years, Liabilities and Shareholders Equity stood at $12.3 million in 2022, then sank by 96.84% to $389000.0 in 2023, then surged by 1063.24% to $4.5 million in 2024, then jumped by 165.15% to $12.0 million in 2025, then soared by 59.11% to $19.1 million in 2026.
  • According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $19.1 million, $12.0 million, and $84000.0 for Q2 2026, Q4 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Teva Pharmaceutical Industries 46.72 Bn 43.07 Bn 2.15 Bn 39.86 Bn
2 Viatris 19.64 Bn 18.75 Bn 1.46 Bn 35.04 Bn
3 Dr Reddys Laboratories 10.36 Bn 10.22 Bn 396.53 Mn 6.08 Bn
4 Amneal Pharmaceuticals 6.44 Bn 6.39 Bn 334.51 Mn 3.78 Bn
5 Bausch Health Companies 2.11 Bn 1.24 Bn 2.10 Bn 24.79 Bn
6 Ani Pharmaceuticals 1.88 Bn 1.52 Bn 165.89 Mn 1.49 Bn
7 Alvotech 1.83 Bn 1.69 Bn 2.56 Mn 1.59 Bn
8 Amphastar Pharmaceuticals 1.04 Bn 751.07 Mn 93.47 Mn 1.74 Bn
9 Fennec Pharmaceuticals 382.22 Mn 340.97 Mn 17.15 Mn 75.75 Mn
10 PRF Technologies 622,054.07 -10.31 Mn - 19.09 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.09 Mn
Dec 31, 2025 12.00 Mn
Jun 30, 2025 84,000.00
Dec 31, 2024 4.53 Mn
Jun 30, 2024 3.11 Mn
Mar 31, 2024 5.37 Mn
Dec 31, 2023 389,000.00
Sep 30, 2023 10.89 Mn
Jun 30, 2023 8.32 Mn
Mar 31, 2023 10.42 Mn
Dec 31, 2022 12.33 Mn
Sep 30, 2022 14.85 Mn
Jun 30, 2022 15.99 Mn
Mar 31, 2022 17.71 Mn
Dec 31, 2021 19.07 Mn
Sep 30, 2021 20.34 Mn
Jun 30, 2021 19.84 Mn
Mar 31, 2021 21.35 Mn
Dec 31, 2020 17.80 Mn
Jun 30, 2020 838,000.00
API Access

PRF Technologies Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PRFX&period=max&api_key=YOUR_API_KEY